|
GB2472856B
(en)
|
2009-08-21 |
2012-07-11 |
Cantargia Ab |
IL1-RAP modulators and uses thereof
|
|
JP5940093B2
(ja)
|
2011-01-19 |
2016-06-29 |
カンタージア アクチエボラーグ |
抗ｉｌ−１ｒａｐ抗体及びヒトを処置するためのそれらの使用
|
|
EP2934532B1
(en)
|
2012-12-20 |
2019-10-23 |
Purdue Research Foundation |
Chimeric antigen receptor-expressing t cells as anti-cancer therapeutics
|
|
HRP20210977T1
(hr)
|
2014-02-10 |
2021-09-17 |
Merck Patent Gmbh |
Ciljano inhibiranje tgf beta
|
|
GB201403875D0
(en)
|
2014-03-05 |
2014-04-16 |
Cantargia Ab |
Novel antibodies and uses thereof
|
|
US11708608B2
(en)
|
2014-11-10 |
2023-07-25 |
Genentech, Inc. |
Therapeutic and diagnostic methods for IL-33-mediated disorders
|
|
JP6929771B2
(ja)
|
2014-11-10 |
2021-09-01 |
ジェネンテック， インコーポレイテッド |
抗インターロイキン−３３抗体及びその使用
|
|
CN108026172B
(zh)
|
2015-06-26 |
2022-04-29 |
赛诺菲生物技术公司 |
单克隆抗il-1racp抗体
|
|
SG10201913573UA
(en)
*
|
2015-10-01 |
2020-03-30 |
Heat Biologics Inc |
Compositions and methods for adjoining type i and type ii extracellular domains as heterologous chimeric proteins
|
|
CN108603877A
(zh)
*
|
2015-10-02 |
2018-09-28 |
Tgr生物科学私人有限公司 |
使用多基质的分析物检测
|
|
BR112018008908A2
(pt)
*
|
2015-11-02 |
2018-11-27 |
Janssen Pharmaceutica Nv |
anticorpos anti-il1rap, moléculas de ligação ao antígeno biespecíficas que se ligam il1rap e cd3, e seus usos
|
|
CA3019835A1
(en)
|
2016-04-08 |
2017-10-12 |
Purdue Research Foundation |
Methods and compositions for car t cell therapy
|
|
EP3241845A1
(en)
|
2016-05-06 |
2017-11-08 |
MAB Discovery GmbH |
Humanized anti-il-1r3 antibodies
|
|
CA3084459A1
(en)
*
|
2016-10-16 |
2018-04-19 |
Cellerant Therapeutics, Inc. |
Anti-il1-rap antibodies
|
|
RS67792B1
(sr)
|
2016-12-01 |
2026-03-31 |
Regeneron Pharma |
Radio-obeležena anti-pd-l1 antitela za imuno-pet snimanje
|
|
CN110352068A
(zh)
|
2016-12-02 |
2019-10-18 |
南加利福尼亚大学 |
合成的免疫受体及其使用方法
|
|
AU2018219226B2
(en)
|
2017-02-07 |
2024-12-19 |
Seattle Children's Hospital (dba Seattle Children's Research Institute) |
Phospholipid ether (PLE) CAR T cell tumor targeting (CTCT) agents
|
|
BR112019016336A2
(pt)
|
2017-02-10 |
2020-03-31 |
Regeneron Pharmaceuticals, Inc. |
Conjugado de anticorpo radiorrotulado, método para imageamento de um tecido que expressa lag3 e para tratar um tumor, e, composto.
|
|
CN110582288B
(zh)
|
2017-02-28 |
2024-09-20 |
恩多塞特公司 |
用于car t细胞疗法的组合物和方法
|
|
WO2018169922A2
(en)
*
|
2017-03-13 |
2018-09-20 |
Kite Pharma, Inc. |
Chimeric antigen receptors for melanoma and uses thereof
|
|
WO2018204872A2
(en)
|
2017-05-05 |
2018-11-08 |
Fusion Pharmaceuticals Inc. |
Igf-1r monoclonal antibodies and uses thereof
|
|
US10093741B1
(en)
*
|
2017-05-05 |
2018-10-09 |
Fusion Pharmaceuticals Inc. |
IGF-1R monoclonal antibodies and uses thereof
|
|
AU2018261888B2
(en)
|
2017-05-05 |
2022-06-30 |
Centre For Probe Development And Commercialization |
Pharmacokinetic enhancements of bifunctional chelates and uses thereof
|
|
EP3401332A1
(en)
|
2017-05-08 |
2018-11-14 |
MAB Discovery GmbH |
Anti-il-1r3 antibodies for use in inflammatory conditions
|
|
WO2018231827A1
(en)
|
2017-06-12 |
2018-12-20 |
Bluefin Biomedicine, Inc. |
Anti-il1rap antibodies and antibody drug conjugates
|
|
CN110997013B
(zh)
|
2017-07-24 |
2022-09-20 |
瑞泽恩制药公司 |
抗cd8抗体和其用途
|
|
US11370842B2
(en)
|
2017-08-01 |
2022-06-28 |
City Of Hope |
Anti-IL1RAP antibodies
|
|
EP3489259A1
(en)
*
|
2017-11-23 |
2019-05-29 |
Etablissement Français du Sang |
Anti-il-1rap-car-t cells and their use
|
|
WO2019144095A1
(en)
|
2018-01-22 |
2019-07-25 |
Seattle Children's Hospital (dba Seattle Children's Research Institute) |
Methods of use for car t cells
|
|
AU2019218729B2
(en)
|
2018-02-06 |
2025-12-04 |
Seattle Children's Hospital (dba Seattle Children's Research Institute) |
Fluorescein-specific CARs exhibiting optimal T cell function against FL-PLE labelled tumors
|
|
JP7568224B2
(ja)
|
2018-02-23 |
2024-10-16 |
エンドサイト・インコーポレイテッド |
Ｃａｒ ｔ細胞療法のための配列決定法
|
|
CN110759989B
(zh)
*
|
2018-07-27 |
2021-08-17 |
中国人民解放军总医院 |
IL-36γ作为动脉粥样硬化的标志物
|
|
JP2022532812A
(ja)
*
|
2018-08-16 |
2022-07-20 |
カンタージア アクチエボラーグ |
抗ｉｌ１ｒａｐ抗体組成物
|
|
TW202021618A
(zh)
|
2018-08-17 |
2020-06-16 |
美商２３與我有限公司 |
抗ｉｌ１ｒａｐ抗體及其使用方法
|
|
IT201800009282A1
(it)
*
|
2018-10-09 |
2020-04-09 |
Metis Prec Medicine Sb Srl |
Nuovo agente terapeutico per il trattamento di un tumore e/o metastasi
|
|
US12331320B2
(en)
|
2018-10-10 |
2025-06-17 |
The Research Foundation For The State University Of New York |
Genome edited cancer cell vaccines
|
|
KR20210099073A
(ko)
*
|
2018-12-03 |
2021-08-11 |
퓨전 파마슈티칼즈 인크. |
방사성면역접합체와 체크포인트 억제제의 조합 요법
|
|
MX2021007589A
(es)
|
2018-12-21 |
2021-12-10 |
23Andme Inc |
Anticuerpos anti il-36 y procedimientos de uso de estos.
|
|
EP3930687A4
(en)
|
2019-02-25 |
2023-06-07 |
The University of Chicago |
METHODS AND COMPOSITIONS FOR THE TREATMENT OF INFLAMMATORY AND AUTOIMMUNE CONDITIONS USING ECM AFFINITY PEPTIDES LINKED TO ANTI-INFLAMMATORY AGENTS
|
|
CN110564848A
(zh)
*
|
2019-04-15 |
2019-12-13 |
上海市同仁医院 |
白介素-36在制备结直肠癌预后产品中的应用
|
|
WO2020215051A1
(en)
*
|
2019-04-19 |
2020-10-22 |
Rpi Consulting Llc |
Treatments for pregnancy-related conditions
|
|
CA3143211A1
(en)
*
|
2019-06-26 |
2020-12-30 |
Glaxosmithkline Intellectual Property Development Limited |
Il1rap binding proteins
|
|
EP4013794A4
(en)
|
2019-08-12 |
2023-11-22 |
City of Hope |
ANTI-IL1RAP ANTIBODIES
|
|
CN114340684B
(zh)
|
2019-09-16 |
2025-09-12 |
瑞泽恩制药公司 |
用于免疫pet成像的放射性标记的met结合蛋白
|
|
IL295063A
(en)
|
2020-02-04 |
2022-09-01 |
Seattle Childrens Hospital Dba Seattle Childrens Res Inst |
Chimeric antigen receptors (car) against dinitrophenol
|
|
EP4118114A1
(en)
|
2020-03-13 |
2023-01-18 |
Genentech, Inc. |
Anti-interleukin-33 antibodies and uses thereof
|
|
AU2021251269A1
(en)
*
|
2020-04-10 |
2022-11-17 |
Provincial Health Services Authority |
Binders and chimeric antigen receptors specific for interleukin-1 receptor accessory protein
|
|
CN121914272A
(zh)
*
|
2020-05-12 |
2026-04-24 |
正大天晴药业集团股份有限公司 |
St2抗原结合蛋白
|
|
PE20231575A1
(es)
*
|
2020-09-14 |
2023-10-04 |
Ichnos Sciences SA |
Anticuerpos que se unen a il1rap y usos de estos
|
|
MX2023007611A
(es)
|
2020-12-23 |
2023-07-12 |
Cantargia Ab |
Anticuerpo anti-il1rap.
|
|
EP4288457A2
(en)
*
|
2021-02-05 |
2023-12-13 |
Boehringer Ingelheim International GmbH |
Anti-il1rap antibodies
|
|
MX2023013714A
(es)
|
2021-05-21 |
2024-01-16 |
Leo Pharma As |
Anticuerpos anti-proteina accesoria del receptor de interleucina 1 (il-1).
|
|
AU2023303517A1
(en)
*
|
2022-07-06 |
2025-01-23 |
Bluefin Biomedicine, Inc. |
Methods of treating disease using anti-il1rap antibodies and antibody drug conjugates
|
|
US12054552B2
(en)
|
2022-09-21 |
2024-08-06 |
Sanofi Biotechnology |
Humanized anti-IL-1R3 antibody and methods of use
|
|
JP2026517839A
(ja)
*
|
2023-05-05 |
2026-06-02 |
大塚製薬株式会社 |
抗ｉｌ１ｒａｐ抗体
|
|
TW202530255A
(zh)
*
|
2023-12-15 |
2025-08-01 |
法商亞維西亞有限公司 |
抗ｉｌ－１ｒａｐ結合結構域及其抗體－藥物偶聯物
|
|
WO2025201513A1
(zh)
*
|
2024-03-29 |
2025-10-02 |
珠海丹序生物制药有限公司 |
抗il1rap抗体及其用途
|
|
WO2026022232A1
(en)
|
2024-07-24 |
2026-01-29 |
Almirall, S.A. |
Il-1rap inhibitor for treating or preventing hidradenitis suppurativa
|
|
CN118772268B
(zh)
*
|
2024-09-10 |
2025-02-11 |
山东第二医科大学 |
猴痘病毒a29l单克隆抗体、试剂盒及应用
|